Academic Journal

NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia

التفاصيل البيبلوغرافية
العنوان: NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia
المؤلفون: Li, Yonghong, Solis-Ruiz, Jose, Yang, Fei, Long, Nicola, Tong, Carmen H., Lacbawan, Felicitas L., Racke, Frederick K., Press, Richard D.
المصدر: Blood Cancer Journal ; volume 13, issue 1 ; ISSN 2044-5385
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2023
الوصف: Treated AML patients often have measurable residual disease (MRD) due to persisting low-level clones. This study assessed whether residual post-treatment somatic mutations, detected by NGS, were significantly prognostic for subsequent clinical outcomes. AML patients ( n = 128) underwent both pre-and post-treatment testing with the same 42-gene MRD-validated NGS assay. After induction, 59 (46%) patients were mutation-negative (0.0024 VAF detection limit) and 69 (54%) had ≥1 persisting NGS-detectable mutation. Compared with NGS-negative patients, NGS-positive patients had shorter overall survival (17 months versus median not reached; P = 0.004; hazard ratio = 2.2 [95% CI: 1.3–3.7]) and a shorter time to relapse (14 months versus median not reached; P = 0.014; HR = 1.9 [95% CI: 1.1–3.1]). Among 95 patients with a complete morphologic remission (CR), 43 (45%) were MRD-positive by NGS and 52 (55%) were MRD-negative. These MRD-positive CR patients had a shorter overall survival (16.8 months versus median not reached; P = 0.013; HR = 2.1 [95% CI: 1.2–3.9]) than did the MRD-negative CR patients. Post-treatment persisting MRD positivity, defined by the same NGS-based test used at diagnosis, is thus a more sensitive biomarker for low-level leukemic clones compared to traditional non-molecular methods and is prognostic of subsequent relapse and death.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1038/s41408-023-00833-7
الاتاحة: http://dx.doi.org/10.1038/s41408-023-00833-7
https://www.nature.com/articles/s41408-023-00833-7.pdf
https://www.nature.com/articles/s41408-023-00833-7
Rights: https://creativecommons.org/licenses/by/4.0 ; https://creativecommons.org/licenses/by/4.0
رقم الانضمام: edsbas.EFD93387
قاعدة البيانات: BASE
الوصف
DOI:10.1038/s41408-023-00833-7